Treatment outcome and long-term prognosis of antiviral therapy for chronic B or C infection-A multicenter cohort study

Treatment outcome and long-term prognosis of antiviral therapy for chronic B or C infection-A multicenter cohort study - Treatment outcome of antiviral therapy for chronic B or C infection

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034696

Enrollment

5000

Registered

2018-10-30

Start date

2017-04-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B or C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) HBV: Patients with receiving nucleos(t)ide analogue treatment (2) HCV: Patients with past history of DAA treatment

Exclusion criteria

Exclusion criteria: Any other clinical conditions that, in the opinion of the investigator, would make the subject unsuitable or unable to comply with any of the study procedures

Design outcomes

Primary

Measure	Time frame
Virological effect and the development of hepatocellular carcinoma after the antiviral therapy	—

Countries

Japan

Contacts

Public ContactEiichi Ogawa

Kyushu University Hospital Department of General Internal Medicine

e.ogawa.a65@m.kyushu-u.ac.jp092-642-5909

Outcome results